<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00063453</url>
  </required_header>
  <id_info>
    <org_study_id>151</org_study_id>
    <secondary_id>R01HL071022</secondary_id>
    <nct_id>NCT00063453</nct_id>
    <nct_alias>NCT00241865</nct_alias>
    <nct_alias>NCT00782678</nct_alias>
  </id_info>
  <brief_title>Supplemental Selenium and Vitamin E and Pulmonary Function</brief_title>
  <official_title>The Respiratory Ancillary Study (RAS) to SELECT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Cornell University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test whether supplementation with selenium and/or vitamin E affects pulmonary function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      There is compelling evidence from observational epidemiologic studies that intakes of
      nutrients with antioxidant properties are associated with reduced risks of chronic
      obstructive disease (COPD) and increased lung function. This study is ancillary to the
      multisite Selenium and Vitamin E Cancer Prevention Trial (SELECT), a 4-arm
      placebo-controlled, double-blinded randomized trial in 35,000 men testing whether daily
      supplementation with vitamin E (400mg alpha-tocopherol), selenium (200 micrograms
      selenomethionine) or both vitamin E and selenium can prevent prostate cancer.

      DESIGN NARRATIVE:

      This study is ancillary to the multisite Selenium and Vitamin E Cancer Prevention Trial
      (SELECT), a 4-arm placebo-controlled, double-blinded randomized trial in 35,000 men testing
      whether daily supplementation with vitamin E (400mg alpha-tocopherol), selenium (200
      micrograms selenomethionine) or both vitamin E and selenium can prevent prostate cancer. A
      total of 3,000 SELECT participants will be enrolled for this respiratory ancillary study, and
      data collection will be extended to include pulmonary function, respiratory disease, and
      respiratory symptoms. Biological measures of nutrient exposure (serum vitamin E and selenium)
      and plasma lipids (total and high-density lipoprotein cholesterol) will be collected on all
      participants and oxidant burden (urinary F2-isoprostane) on a sub sample of heavy smokers and
      men with COPD. The primary outcome will be change over about 36 months in forced expiratory
      volume in the first second (FEV1). FEV1 is a valid and reliable measure of respiratory
      function that strongly predicts COPD and mortality. Extensive data on diet and dietary
      supplement use are being collected by the SELECT parent study. All specific aims examine
      pre-specified contrasts between the 4 arms of the SELECT randomized trial. The underlying
      hypothesis is that supplements will reduce the age related decline in FEV1 and thus at the
      3-year follow-up FEV1, which will be tested in longitudinal and cross-sectional models. A
      secondary aim considers whether the effect of supplementation is greater among smokers (high
      burden of exogenous oxidants) who, by purposive selection of the study sites, will comprise
      about 25% of the sample.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pulmonary function over time by arm of study</measure>
    <time_frame>Outcome is assessed at annual and bi-annual study visits, during in-person visit of participant to the study site. Over a period of about 36 to 48 months, participants are assessed between 3 and 4 times</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Effect of selenium and vitamin E supplementation on incidence of COPD</measure>
    <time_frame>Questionnaire data on incident lung disease is assessed at annual and biannual study visits, in all SELECT participants. These questionnaire data were collected through the end of SELECT active follow-up, which was December 2010</time_frame>
    <description>The incidence of COPD will be assessed in the full SELECT trial, given this ancillary study added questionnaire data to assess self-reported incidence of lung disease in the full 35,000 participants</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">2920</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Lung Diseases</condition>
  <condition>Lung Diseases, Obstructive</condition>
  <arm_group>
    <arm_group_label>Vitamin E and selenium placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin E alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Selenium and vitamin E placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Selenium alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin E and selenium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin E and selenium combined</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vitamin E Placebo and Selenium placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Double placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <description>vitamin E (400 IU/day all rac-α-tocopheryl acetate)</description>
    <arm_group_label>Vitamin E and selenium placebo</arm_group_label>
    <arm_group_label>Vitamin E and selenium</arm_group_label>
    <other_name>all rac-α-tocopheryl acetate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Selenium</intervention_name>
    <description>selenium (200 μg/d L-selenomethionine)</description>
    <arm_group_label>Selenium and vitamin E placebo</arm_group_label>
    <arm_group_label>Vitamin E and selenium</arm_group_label>
    <other_name>L-selenomethionine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin E placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>Selenium and vitamin E placebo</arm_group_label>
    <arm_group_label>vitamin E Placebo and Selenium placebo</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Selenium placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>Vitamin E and selenium placebo</arm_group_label>
    <arm_group_label>vitamin E Placebo and Selenium placebo</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligibility criteria:

          -  age ≥ 55 y (≥ 50 y in African-Americans)

          -  serum prostate-specific antigen ≤ 4ng/mL

          -  no clinical evidence of prostate cancer

        Exclusion criteria:

          -  Off both SELECT supplements
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia A. Cassano, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cornell University</affiliation>
  </overall_official>
  <link>
    <url>http://www.human.cornell.edu/bio.cfm?netid=pac6</url>
    <description>Patricia A. Cassano homepage</description>
  </link>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2003</study_first_submitted>
  <study_first_submitted_qc>June 27, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2003</study_first_posted>
  <last_update_submitted>December 8, 2017</last_update_submitted>
  <last_update_submitted_qc>December 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
    <mesh_term>Selenium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

